EP1183267A4 - Peptides r tro-inverses d riv s de l'interleukine 6 - Google Patents

Peptides r tro-inverses d riv s de l'interleukine 6

Info

Publication number
EP1183267A4
EP1183267A4 EP00952761A EP00952761A EP1183267A4 EP 1183267 A4 EP1183267 A4 EP 1183267A4 EP 00952761 A EP00952761 A EP 00952761A EP 00952761 A EP00952761 A EP 00952761A EP 1183267 A4 EP1183267 A4 EP 1183267A4
Authority
EP
European Patent Office
Prior art keywords
retro
interleukin
peptides derived
inverso peptides
inverso
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00952761A
Other languages
German (de)
English (en)
Other versions
EP1183267A1 (fr
Inventor
David E Wright
D Elliot Parks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Myelos Corp
Original Assignee
Myelos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myelos Corp filed Critical Myelos Corp
Publication of EP1183267A1 publication Critical patent/EP1183267A1/fr
Publication of EP1183267A4 publication Critical patent/EP1183267A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP00952761A 1999-06-16 2000-06-16 Peptides r tro-inverses d riv s de l'interleukine 6 Withdrawn EP1183267A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13968799P 1999-06-16 1999-06-16
PCT/US2000/040227 WO2000077033A1 (fr) 1999-06-16 2000-06-16 Peptides rétro-inverses dérivés de l'interleukine 6
US139687P 2008-12-22

Publications (2)

Publication Number Publication Date
EP1183267A1 EP1183267A1 (fr) 2002-03-06
EP1183267A4 true EP1183267A4 (fr) 2002-09-18

Family

ID=22487847

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00952761A Withdrawn EP1183267A4 (fr) 1999-06-16 2000-06-16 Peptides r tro-inverses d riv s de l'interleukine 6

Country Status (6)

Country Link
EP (1) EP1183267A4 (fr)
JP (1) JP4786843B2 (fr)
AU (1) AU6540500A (fr)
CA (1) CA2376479A1 (fr)
IL (3) IL147094A0 (fr)
WO (1) WO2000077033A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003821A1 (fr) * 1993-07-30 1995-02-09 The Regents Of The University Of California Prosaposine et peptides derives de la cytokine utilises comme agents therapeutiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
EP0979238A4 (fr) * 1997-03-05 2000-08-23 Univ California Procedes pour soulager les douleurs neuropathiques
US6458357B1 (en) * 1997-09-09 2002-10-01 Myelos Corporation Retro-inverso neurotrophic and analgesic peptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003821A1 (fr) * 1993-07-30 1995-02-09 The Regents Of The University Of California Prosaposine et peptides derives de la cytokine utilises comme agents therapeutiques

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DERETZI G ET AL.: "Suppression of chronic experimental autoimmune neuritis by nasally administered recombinant rat interleukin-6", IMMUNOLOGY, vol. 97, no. 1, May 1999 (1999-05-01), pages 69 - 76, XP002206393 *
IHARA S ET AL.: "Identification of Interleukin-6 as a Factor That Induces Neurite Outgrowth by PC12 Cells Primed with NGF", THE JOURNAL OF BIOCHEMISTRY, vol. 120, no. 5, 1996, pages 865 - 868, XP002206392 *
See also references of WO0077033A1 *

Also Published As

Publication number Publication date
CA2376479A1 (fr) 2000-12-21
IL147094A0 (en) 2002-08-14
IL147094A (en) 2011-04-28
EP1183267A1 (fr) 2002-03-06
JP2003502343A (ja) 2003-01-21
WO2000077033A1 (fr) 2000-12-21
IL190034A0 (en) 2011-08-01
JP4786843B2 (ja) 2011-10-05
AU6540500A (en) 2001-01-02

Similar Documents

Publication Publication Date Title
HK1036997A1 (en) Peptides
IL146832A0 (en) Peptides
EP1185558A4 (fr) Peptide ayant une fonctionnalite preptine
IL150458A0 (en) Novel haptotactic peptides
EP1147130A4 (fr) Peptides d'alpha-conotoxine
GB9812675D0 (en) Peptides
IL147095A (en) Retro-inverso peptides derived from leukemia inhibitory factor
EP1159288A4 (fr) Peptides alpha-conotoxine
IL147093A0 (en) Retro-inverso peptides derived from interleukin-3
GB9904695D0 (en) Peptide
IL147094A0 (en) Retro-inverso peptides derived from interleukin-6
GB0001825D0 (en) Peptides
IL144376A0 (en) Peptides
GB9908920D0 (en) Peptide
GB9807890D0 (en) Peptides
EP1151100A4 (fr) Peptides designes tau-conotoxines
EP1323731A4 (fr) Nouveaux peptides
GB9918595D0 (en) Novel peptides
GB9918597D0 (en) Novel peptides
GB9918603D0 (en) Novel peptides
GB9918606D0 (en) Novel peptides
GB9918594D0 (en) Novel peptides
GB9918604D0 (en) Novel peptides
GB9918596D0 (en) Novel peptides
GB9918598D0 (en) Novel peptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011214

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07K 14/54 A, 7A 61K 38/20 B, 7A 61P 25/00 B

A4 Supplementary search report drawn up and despatched

Effective date: 20020802

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030226

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030709

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1042712

Country of ref document: HK